Institute of Health and Biomedical Innovation, Queensland University of Technology , Brisbane, Queensland QLD 4059, Australia.
Institute for Molecular Bioscience, The University of Queensland , 306 Carmody Road, Building 80, Queensland Bioscience Presinct, Brisbane, Queensland, QLD 4072, Australia.
J Med Chem. 2015 Oct 22;58(20):8257-68. doi: 10.1021/acs.jmedchem.5b01148. Epub 2015 Oct 5.
Standard mechanism inhibitors are attractive design templates for engineering reversible serine protease inhibitors. When optimizing interactions between the inhibitor and target protease, many studies focus on the nonprimed segment of the inhibitor's binding loop (encompassing the contact β-strand). However, there are currently few methods for screening residues on the primed segment. Here, we designed a synthetic inhibitor library (based on sunflower trypsin inhibitor-1) for characterizing the P2' specificity of various serine proteases. Screening the library against 13 different proteases revealed unique P2' preferences for trypsin, chymotrypsin, matriptase, plasmin, thrombin, four kallikrein-related peptidases, and several clotting factors. Using this information to modify existing engineered inhibitors yielded new variants that showed considerably improved selectivity, reaching up to 7000-fold selectivity over certain off-target proteases. Our study demonstrates the importance of the P2' residue in standard mechanism inhibition and unveils a new approach for screening P2' substitutions that will benefit future inhibitor engineering studies.
标准机制抑制剂是工程可逆丝氨酸蛋白酶抑制剂的有吸引力的设计模板。在优化抑制剂与目标蛋白酶之间的相互作用时,许多研究都集中在抑制剂结合环的非先导段(包括接触β-链)上。然而,目前很少有方法可以筛选先导段上的残基。在这里,我们设计了一个合成抑制剂文库(基于向日葵胰蛋白酶抑制剂-1),用于表征各种丝氨酸蛋白酶的 P2'特异性。该文库针对 13 种不同的蛋白酶进行筛选,揭示了胰蛋白酶、糜蛋白酶、组织蛋白酶、纤溶酶、凝血酶、4 种激肽释放酶相关肽酶和几种凝血因子的独特 P2'偏好。利用这些信息对现有工程化抑制剂进行修饰,得到了新的变体,其选择性得到了显著提高,对某些非靶标蛋白酶的选择性高达 7000 倍。我们的研究表明了 P2'残基在标准机制抑制中的重要性,并揭示了一种筛选 P2'取代的新方法,这将有益于未来的抑制剂工程研究。